Arcutis Biotherapeutics, Inc. (ARQT)
31.20
-1.00
(-3.11%)
USD |
NASDAQ |
Oct 23, 16:00
31.20
0.00 (0.00%)
After-Hours: 20:00
Arcutis Biotherapeutics Price : 31.20 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 32.13 | 32.13 | 30.91 | 31.20 | 1.894M |
| Oct 22, 2026 | 31.68 | 32.50 | 31.35 | 32.20 | 2.076M |
| Oct 21, 2026 | 32.64 | 32.94 | 31.65 | 31.87 | 1.689M |
| Oct 20, 2026 | 31.89 | 33.30 | 31.75 | 32.82 | 4.491M |
| Oct 19, 2026 | 29.41 | 33.01 | 28.99 | 31.89 | 5.796M |
| Oct 16, 2026 | 29.18 | 29.37 | 28.15 | 28.82 | 1.802M |
| Oct 15, 2026 | 26.93 | 29.46 | 26.93 | 29.10 | 3.956M |
| Oct 14, 2026 | 26.01 | 26.94 | 25.86 | 26.41 | 1.647M |
| Oct 13, 2026 | 25.93 | 26.57 | 25.60 | 26.09 | 1.889M |
| Oct 12, 2026 | 26.54 | 26.82 | 25.97 | 26.22 | 1.557M |
| Oct 09, 2026 | 24.50 | 26.97 | 24.30 | 26.58 | 1.732M |
| Oct 08, 2026 | 23.91 | 24.57 | 23.37 | 24.49 | 2.606M |
| Oct 07, 2026 | 23.74 | 24.38 | 23.51 | 24.17 | 1.726M |
| Oct 06, 2026 | 25.37 | 25.37 | 23.88 | 23.92 | 2.573M |
| Oct 05, 2026 | 25.09 | 25.38 | 24.69 | 25.15 | 2.310M |
| Oct 02, 2026 | 25.64 | 25.78 | 25.01 | 25.16 | 1.778M |
| Oct 01, 2026 | 26.10 | 26.44 | 25.22 | 25.29 | 1.637M |
| Sep 30, 2026 | 27.00 | 27.39 | 26.41 | 26.43 | 2.391M |
| Sep 29, 2026 | 27.21 | 27.64 | 26.73 | 26.75 | 2.937M |
| Sep 28, 2026 | 26.70 | 27.55 | 26.43 | 27.33 | 3.066M |
| Sep 25, 2026 | 26.55 | 27.09 | 25.80 | 26.92 | 2.040M |
| Sep 24, 2026 | 26.22 | 26.68 | 25.19 | 26.27 | 2.178M |
| Sep 23, 2026 | 27.79 | 28.02 | 26.07 | 26.38 | 2.512M |
| Sep 22, 2026 | 25.90 | 28.29 | 25.69 | 27.78 | 2.858M |
| Sep 21, 2026 | 25.57 | 26.08 | 25.19 | 25.96 | 1.888M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Insmed, Inc. | 93.39 |
| Emergent BioSolutions, Inc. | 6.23 |
| Exelixis, Inc. | 64.53 |
| Puma Biotechnology, Inc. | 11.02 |
Price Related Metrics
| PE Ratio | 150.65 |
| PS Ratio | 8.973 |
| Price to Book Value | 17.76 |
| Price to Free Cash Flow | 106.34 |
| Earnings Yield | 0.66% |
| Market Cap | 3.918B |
| Operating PE Ratio | 121.55 |
| Normalized PE Ratio | 150.36 |